Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire.

Zelazowska MA, Dong Q, Plummer JB, Zhong Y, Liu B, Krug LT, McBride KM.

Life Sci Alliance. 2020 Feb 6;3(3). pii: e201900526. doi: 10.26508/lsa.201900526. Print 2020 Mar.

2.

Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies.

McBride KM, Kil H, Mu Y, Plummer JB, Lee J, Zelazowski MJ, Sebastian M, Abba MC, Aldaz CM.

Front Oncol. 2019 Jun 19;9:517. doi: 10.3389/fonc.2019.00517. eCollection 2019.

3.

Combinatorial Loss of the Enzymatic Activities of Viral Uracil-DNA Glycosylase and Viral dUTPase Impairs Murine Gammaherpesvirus Pathogenesis and Leads to Increased Recombination-Based Deletion in the Viral Genome.

Dong Q, Smith KR, Oldenburg DG, Shapiro M, Schutt WR, Malik L, Plummer JB, Mu Y, MacCarthy T, White DW, McBride KM, Krug LT.

mBio. 2018 Oct 30;9(5). pii: e01831-18. doi: 10.1128/mBio.01831-18.

4.

Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma.

Krishnamurthy J, Rabinovich BA, Mi T, Switzer KC, Olivares S, Maiti SN, Plummer JB, Singh H, Kumaresan PR, Huls HM, Wang-Johanning F, Cooper LJ.

Clin Cancer Res. 2015 Jul 15;21(14):3241-51. doi: 10.1158/1078-0432.CCR-14-3197. Epub 2015 Mar 31.

5.

Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.

Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F.

Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.

6.

Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.

Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S, Johanning GL.

Int J Cancer. 2014 Feb 1;134(3):587-95. doi: 10.1002/ijc.28389. Epub 2013 Sep 13.

7.

Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Zhao J, Rycaj K, Geng S, Li M, Plummer JB, Yin B, Liu H, Xu X, Zhang Y, Yan Y, Glynn SA, Dorsey TH, Ambs S, Johanning GL, Gu L, Wang-Johanning F.

Genes Cancer. 2011 Sep;2(9):914-22. doi: 10.1177/1947601911431841.

8.

Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.

Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL.

J Natl Cancer Inst. 2012 Feb 8;104(3):189-210. doi: 10.1093/jnci/djr540. Epub 2012 Jan 12.

9.

Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK, Johanning GL.

Cancer Res. 2008 Jul 15;68(14):5869-77. doi: 10.1158/0008-5472.CAN-07-6838.

10.

Sheep stromal-epithelial cell interactions and ovarian tumor progression.

Wang-Johanning F, Huang M, Liu J, Rycaj K, Plummer JB, Barnhart KF, Satterfield WC, Johanning GL.

Int J Cancer. 2007 Nov 15;121(10):2346-54.

11.

The business of private duty--Part Three. Creating budget and cash flow controls.

Plummer JB.

Home Health J. 1987 May;8(5):12-3. No abstract available.

PMID:
10281673
12.

The expanding world of home care.

Plummer JB.

Caring. 1986 Aug;5(8):99-101. No abstract available.

PMID:
10278466

Supplemental Content

Loading ...
Support Center